Search Within

Robert Motzer

Formats
  1. Journal Article (609)
  2. Meeting Abstract (577)
  3. Book Section (20)
  4. Review (13)
  5. Conference Paper (6)
  6. Correspondence (6)
  7. Guidelines (5)
  8. Research Letter (5)
  9. Editorial (3)
  10. Book Whole (2)
Groups
  1. Department of Medicine (1246)
  2. Genitourinary Oncology Service (1246)
  3. Solid Tumor Oncology Division (1246)
  4. Surgery (290)
  5. Urology (281)
  6. Survivorship Research (253)

More Groups

People
  1. George Bosl (182)
  2. Martin Voss (178)
  3. Darren Feldman (158)
  4. Dean Bajorin (128)
  5. Paul Russo (119)
  6. Joel Sheinfeld (110)

More People

Years
  1. 2025 (29)
  2. 2024 (49)
  3. 2023 (47)
  4. 2022 (64)
  5. 2021 (65)
  6. 2020 (65)

More Years

Publications
  1. Journal of Clinical Oncology (447)
  2. Annals of Oncology (81)
  3. BJU International (40)
  4. Cancer (35)
  5. European Journal of Cancer (34)
  6. Clinical Cancer Research (33)

More Publications

Publishers
  1. American Society of Clinical Oncology (450)
  2. Elsevier Science, Inc. (111)
  3. Oxford University Press (111)
  4. Elsevier Inc. (89)
  5. Wiley Blackwell (86)
  6. American Association for Cancer Research (58)

More Publishers

Results (1246)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Sunitinib: A viewpoint by Robert J. Motzer
    Journal Article

    Motzer, R. J.
    Drugs (2006)

    Fulltext@MSK | Save
  • Bleomycin, etoposide, and cisplatin for three cycles compared with etoposide and cisplatin for four cycles in good-risk germ cell tumors: Is there a preferred regimen? - Reply
    Journal Article

    Kondagunta, G. V.; Motzer, R. J.; Bosl, G. J.; Sheinfeld, J.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Chemotherapy for advanced germ cell tumors
    Journal Article

    Kondagunta, G. V.; Motzer, R. J.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Novel targets and therapies for metastatic renal cell carcinoma
    Journal Article

    Feldman, D. R.; Motzer, R. J.
    Oncology (Norwalk) (2006)

    Fulltext@MSK | Save
  • A brief symptom index for advanced renal cell carcinoma
    Journal Article

    Eton, D. T.; Cella, D.; Bacik, J.; Motzer, R. J.
    Health and Quality of Life Outcomes (2006)

    Fulltext@MSK | Save
  • Renal cell carcinoma recurrence after nephrectomy for localized disease: Predicting survival from time of recurrence
    Journal Article

    Eggener, S. E.; Yossepowitch, O.; Pettus, J. A.; Snyder, M. E.; Motzer, R. J.; Russo, P.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Predicting teratoma in the retroperitoneum in men undergoing post-chemotherapy retroperitoneal lymph node dissection
    Journal Article

    Carver, B. S.; Bianco, F. J. Jr; Shayegan, B.; Vickers, A.; Motzer, R. J.; Bosl, G. J.; Sheinfeld, J.
    Journal of Urology (2006)

    Fulltext@MSK | Save
  • Renal cell carcinoma local recurrences: Impact of surgical treatment and concomitant metastasis on survival
    Journal Article

    Bruno, J. J. 2nd; Snyder, M. E.; Motzer, R. J.; Russo, P.
    BJU International (2006)

    Fulltext@MSK | Save
  • Transcriptional program associated with IFN-α response of renal cell carcinoma
    Journal Article

    Banerjee, D.; Chadalavada, R. S. V.; Bourdon, V.; Korkola, J. E.; Motzer, R. J.; Chaganti, R. S. K.
    Journal of Interferon and Cytokine Research (2006)

    Fulltext@MSK | Save
  • Advances in urologic oncology: Results progress from successful interdisciplinary research
    Journal Article

    Bajorin, D. F.; Motzer, R. J.; Bosl, G. J.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save